ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,187Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1844

$1.26M Total Retail Price of All Prescriptions

Rank: 21 out of 1844

813 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 18,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,431 966 S3 1 2
FUROSEMIDE 1,061 873 2 7
LISINOPRIL 836 643 3 4
OMEPRAZOLE 787 587 4 5
POTASSIUM CHLORIDE 780 620 5 16
LEVOTHYROXINE SODIUM 724 572 6 1
AMLODIPINE BESYLATE 526 462 7 6
SIMVASTATIN 492 395 8 3
METOPROLOL TARTRATE 436 352 9 11
PREDNISONE 423 335 10 40
METFORMIN HCL 408 293 11 8
METOPROLOL SUCCINATE 389 349 12 14
CITALOPRAM HBR 366 269 13 19
WARFARIN SODIUM 334 316 14 13
GABAPENTIN 330 218 15 15
QUETIAPINE FUMARATE 313 296 16 82
ZOLPIDEM TARTRATE 297 174 17 23
TRAMADOL HCL 280 228 18 18
DONEPEZIL HCL 263 263 19 26
HYDROCHLOROTHIAZIDE 247 211 20 9
CYMBALTA 222 128 21 36
TAMSULOSIN HCL 218 164 22 27
RANITIDINE HCL 212 123 23 38
MORPHINE SULFATE ER 210 64 S2 24 107
LANTUS 210 160 24 42
RISPERIDONE 209 186 26 65
FLUOXETINE HCL 186 99 27 41
DICLOFENAC SODIUM 184 117 28 122
LOVASTATIN 163 135 29 44
PANTOPRAZOLE SODIUM 158 148 30 32
POLYETHYLENE GLYCOL 3350 156 112 31 39
ALLOPURINOL 149 134 32 29
CLOPIDOGREL 147 98 33 34
SERTRALINE HCL 147 122 33 21
MIRTAZAPINE 145 111 35 49
CARVEDILOL 143 132 36 22
ATORVASTATIN CALCIUM 141 94 37 12
METOCLOPRAMIDE HCL 138 63 38 148
ISOSORBIDE MONONITRATE ER 136 128 39 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 104 40 20
DIGOXIN 128 109 41 67
GLYBURIDE 124 86 R 42 100
DOXYCYCLINE HYCLATE 123 102 43 90
NYSTATIN 122 107 44 85
FLUTICASONE PROPIONATE 121 98 45 50
RAMIPRIL 121 119 45 116
SEROQUEL 121 116 45 191
NAMENDA 120 120 48 33
PROMETHAZINE HCL 118 69 R 49 88
QUINAPRIL HCL 118 92 49 152
PHENYTOIN SODIUM EXTENDED 117 70 51 147
OXYCONTIN 116 62 S2 52 144
AMITRIPTYLINE HCL 116 49 R 52 72
NEXIUM 113 76 54 31
VERAPAMIL ER 113 101 54 98
NOVOLOG 112 78 56 84
LEVOFLOXACIN 111 94 57 78
KLOR-CON M10 109 106 58 149
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 78 59 73
ALENDRONATE SODIUM 108 108 59 25
OXYCODONE-ACETAMINOPHEN 106 90 S2 61 94
PLAVIX 105 73 62 61
FENTANYL 104 73 S2 63 66
DIVALPROEX SODIUM 97 78 64 74
CLONIDINE HCL 96 84 65 64
ESCITALOPRAM OXALATE 94 47 66 52
HYDRALAZINE HCL 91 82 67 120
METHADONE HCL 90 28 S2 68 133
PROAIR HFA 89 67 69 45
CYCLOBENZAPRINE HCL 89 28 R 69 53
HALOPERIDOL 88 76 71 247
ADVAIR DISKUS 87 49 72 51
CARBIDOPA-LEVODOPA 87 84 72 86
FAMOTIDINE 87 59 72 63
ESTRADIOL 81 49 R 75 181
KLOR-CON 8 80 57 76 205
KLOR-CON M20 79 74 77 54
BENAZEPRIL HCL 78 65 78 75
PRAVASTATIN SODIUM 77 67 79 10
GLIPIZIDE 75 46 80 70
ENABLEX 75 72 80 313
LYRICA 75 45 80 92
ATENOLOL 74 69 83 17
OXYCODONE HCL 72 30 S2 84 104
CEPHALEXIN 71 49 85 56
MORPHINE SULFATE 71 37 S2 85 207
CRESTOR 71 47 85 30
CIPROFLOXACIN HCL 69 60 88 62
MUPIROCIN 69 46 88 189
HUMALOG 69 58 88 114
OXYCODONE HCL-ACETAMINOPHEN 68 25 S2 91 83
LEVETIRACETAM 67 35 92 105
INSULIN SYRINGE 67 51 92 111
IPRATROPIUM-ALBUTEROL 64 38 94 113
MECLIZINE HCL 64 38 94 142
FLUOCINONIDE 64 51 94 257
NITROSTAT 63 46 97 261
ALBUTEROL SULFATE 63 51 97 115
DIPHENOXYLATE-ATROPINE 62 39 99 291
ENALAPRIL MALEATE 61 45 100 69
HYDROMORPHONE HCL 61 19 S2 100 269
KLOR-CON 10 61 56 100 123
AVODART 59 46 103 219
EXELON 59 59 103 112
LOPERAMIDE 58 56 105 216
IBUPROFEN 57 46 106 89
SINGULAIR 54 25 107 102
SPIRONOLACTONE 54 54 107 60
DILTIAZEM 24HR CD 54 53 107 132
OXYBUTYNIN CHLORIDE ER 54 43 107 126
PREMARIN 53 32 R 111 171
TRAZODONE HCL 53 25 111 43
FLUVOXAMINE MALEATE 51 27 113 451
SEROQUEL XR 51 51 113 239
CELEBREX 51 51 113 91
METHOCARBAMOL 50 30 R 116 241
OLANZAPINE 50 33 116 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.